Indeed, President Jeffrey is correct that, conceptually, other laboratories in the level 4 space operate in the same way with respect to the need for additional security screening prior to having access to level 3 and level 4 pathogens, particularly security-sensitive ones.
However, the specific mechanics of how that is ascertained is done at the country level.